High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
Trial ID or NCT#
Status
Purpose
This study uses a sequence of high-dose chemotherapy drugs and a stem cell transplant to treat multiple myeloma. The study is being performed to evaluate the efficacy and side effects of treatment. Specifically, the study is designed to reduce the risk of interstitial pneumonitis.
Official Title
High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
BMT Referrals
6507230822
View on ClinicalTrials.gov